EDITAS MEDICINE ($EDIT) posted quarterly earnings results for Q3 2026 on Monday, November 9th. The company reported earnings of -$0.15 per share, beating estimates of -$0.19 by $0.04. The company also reported revenue of $10,370,000, beating estimates of $4,549,118 by $5,820,882.
You can see Quiver Quantitative's $EDIT stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
EDITAS MEDICINE Insider Trading Activity
EDITAS MEDICINE insiders have traded $EDIT stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $EDIT stock by insiders over the last 6 months:
- GILMORE NEIL O'NEILL (CEO) has made 0 purchases and 2 sales selling 20,504 shares for an estimated $57,105.
- LINDA BURKLY (EVP, CHIEF SCIENTIFIC OFFICER) has made 0 purchases and 3 sales selling 6,368 shares for an estimated $17,285.
- AMY PARISON (SVP, Chief Financial Officer) has made 0 purchases and 3 sales selling 1,595 shares for an estimated $4,378.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
EDITAS MEDICINE Hedge Fund Activity
We have seen 106 institutional investors add shares of EDITAS MEDICINE stock to their portfolio, and 77 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TCG CROSSOVER MANAGEMENT, LLC added 11,111,111 shares (+inf%) to their portfolio in Q2 2026, for an estimated $35,999,999
- RA CAPITAL MANAGEMENT, L.P. added 8,889,000 shares (+inf%) to their portfolio in Q2 2026, for an estimated $28,800,360
- ADAR1 CAPITAL MANAGEMENT, LLC added 8,889,000 shares (+inf%) to their portfolio in Q2 2026, for an estimated $28,800,360
- COMMODORE CAPITAL LP added 8,889,000 shares (+inf%) to their portfolio in Q2 2026, for an estimated $28,800,360
- PARADIGM BIOCAPITAL ADVISORS LP added 5,586,625 shares (+inf%) to their portfolio in Q2 2026, for an estimated $18,100,665
- WOODLINE PARTNERS LP added 3,555,497 shares (+inf%) to their portfolio in Q2 2026, for an estimated $11,519,810
- VIVO CAPITAL, LLC added 3,555,250 shares (+inf%) to their portfolio in Q2 2026, for an estimated $11,519,010
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
